BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 3922561)

  • 1. Place preference conditioning with methylphenidate and nomifensine.
    Martin-Iverson MT; Ortmann R; Fibiger HC
    Brain Res; 1985 Apr; 332(1):59-67. PubMed ID: 3922561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of nomifensine and desipramine on the sequelae of intracerebrally-injected 6-OHDA and 5,6-DHT.
    Waddington JL
    Pharmacol Biochem Behav; 1980 Dec; 13(6):915-7. PubMed ID: 7193877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cocaine-induced place preference conditioning: lack of effects of neuroleptics and 6-hydroxydopamine lesions.
    Spyraki C; Fibiger HC; Phillips AG
    Brain Res; 1982 Dec; 253(1-2):195-203. PubMed ID: 6817851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of haloperidol on amphetamine- and methylphenidate-induced conditioned place preferences and locomotor activity.
    Mithani S; Martin-Iverson MT; Phillips AG; Fibiger HC
    Psychopharmacology (Berl); 1986; 90(2):247-52. PubMed ID: 3097706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of nomifensine on the toxicity of 6-hydroxydopamine for mesotelencephalic dopamine neurons.
    Lees GJ; Kydd RR; Horsburgh RJ; Wright JJ
    Brain Res; 1984 Aug; 308(1):155-8. PubMed ID: 6434148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of nomifensine on the depletion of brain serotonin and catecholamines induced respectively by fenfluramine and 6-hydroxydopamine in rats.
    Samanin R; Bernasconi S; Garattini S
    Eur J Pharmacol; 1975 Dec; 34(2):377-80. PubMed ID: 1234558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Differences in the mechanisms of the stimulant and antidepressive effects of nomifensine].
    Chermat R; Poncelet M; Simon P
    J Pharmacol; 1985; 16(1):7-13. PubMed ID: 2860270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of dopamine-dependent rewarding and locomotor stimulant effects of intravenously-administered methylphenidate in rats.
    Sellings LH; McQuade LE; Clarke PB
    Neuroscience; 2006 Sep; 141(3):1457-68. PubMed ID: 16753267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancement of stereotypy induced by nomifensine in rats during continuous chronic haloperidol treatment.
    Rupniak NM; Jenner P; Marsden CD
    Neurosci Lett; 1984 Sep; 50(1-3):63-5. PubMed ID: 6541767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopaminergic substrates of amphetamine-induced place preference conditioning.
    Spyraki C; Fibiger HC; Phillips AG
    Brain Res; 1982 Dec; 253(1-2):185-93. PubMed ID: 6817850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Central noradrenaline depletion antagonizes aspects of d-amphetamine-induced hyperactivity in the rat.
    Archer T; Fredriksson A; Jonsson G; Lewander T; Mohammed AK; Ross SB; Söderberg U
    Psychopharmacology (Berl); 1986; 88(2):141-6. PubMed ID: 3081924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uptake of [3H]dopamine into dopaminergic and noradrenergic neurones of the isolated neurointermediate lobe of the rat hypophysis. Effects of desipramine and nomifensine.
    Racké K; Muscholl E
    J Neurochem; 1983 Nov; 41(5):1488-91. PubMed ID: 6619880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo effects of benztropine and nomifensine on dopamine and noradrenaline terminals in rat brain.
    Broch OJ
    Eur J Pharmacol; 1979 Oct; 58(4):419-24. PubMed ID: 510376
    [No Abstract]   [Full Text] [Related]  

  • 14. Suppressive effects of intraventricular injected dopamine and nomifensine on muricide induced by thiamine deficiency.
    Abe Y; Tadano T; Yonezawa A; Kisara K
    Pharmacol Biochem Behav; 1987 Jan; 26(1):77-81. PubMed ID: 3104933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biochemical effects of nomifensine on catecholaminergic systems: in vivo studies.
    Algeri S; Ponzio F; Achilli G; Perego C
    Adv Biochem Psychopharmacol; 1982; 31():219-28. PubMed ID: 7080897
    [No Abstract]   [Full Text] [Related]  

  • 16. The acquisition of responding with conditioned reinforcement: effects of pipradrol, methylphenidate, d-amphetamine, and nomifensine.
    Robbins TW
    Psychopharmacology (Berl); 1978 Jun; 58(1):79-87. PubMed ID: 27837
    [No Abstract]   [Full Text] [Related]  

  • 17. Different adaptive responses by rat striatal dopamine synthetic and receptor mechanisms after repeated treatment with d-amphetamine, methylphenidate and nomifensine.
    Algeri S; Brunello N; Vantini G
    Pharmacol Res Commun; 1980 Jul; 12(7):675-81. PubMed ID: 6105682
    [No Abstract]   [Full Text] [Related]  

  • 18. Depletion of catecholamines in the brain of rats differentially affects stimulation of locomotor activity by caffeine, D-amphetamine, and methylphenidate.
    Finn IB; Iuvone PM; Holtzman SG
    Neuropharmacology; 1990 Jul; 29(7):625-31. PubMed ID: 1974712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of nomifensine on the isolated vas deferens of the rat.
    Tayo FM
    Arch Int Pharmacodyn Ther; 1979 Jul; 240(1):94-102. PubMed ID: 508001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Possible involvement of serotonergic neurons in the reduction of locomotor hyperactivity caused by amphetamine in neonatal rats depleted of brain dopamine.
    Heffner TG; Seiden LS
    Brain Res; 1982 Jul; 244(1):81-90. PubMed ID: 6288184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.